ADHD Therapeutics Market to Grow at a Tremendous Pace over the Forecast Period
Market Overview:
The
global ADHD Therapeutics Market
was analyzed by Market Research Future (MRFR) and it was projected that a
notable CAGR will be attained by the market over the forecast period till 2024.
The valuation of the ADHD therapeutics market was further stated to surpass its
previous valuation with the revenue pool getting wider.
ADHD
or Attention deficit hyperactivity disorder is a highly common neurodevelopmental
disorders that occurs during childhood. It is commonly diagnosed in childhood
and is often seen lasting till ones adulthood. Children with ADHD face a number
of issues like controlling impulsive behaviors, paying attention to something,
or being hyperactive. The symptoms of AHDH cannot be easily outgrown with age. The
symptoms continue for a longer duration of time and causes difficulty at home,
at school, or when with friends. Children with ADHD may forget a lot of things
in frequent manner, might daydream a lot, might have problem in getting along
with others, and make careless mistakes.
The
growth of the ADHD therapeutics market Size is primarily driven by the
increasing usage of additives and preservatives in children’s diet, evolving
lifestyles and changing value systems impact the quality of births, growing
adoption of diagnostic guidelines with minimal threshold for diagnosis of ADHD
in regions like South America and Europe, and prevalence of the disorder among
children between the age group of 4 to 17 years. Furthermore, growing awareness
concerning ADHD among patients as well as physicians and lack of standard
diagnostic tests are projected to push the overall growth of the global AHDH
therapeutics market share in the coming
years. At present, stimulant drugs contributes majorly to the revenue
generation of various key regions. Due to low threshold over the diagnostic
criterions, the prevalence of ADHD is expected to rise at a massive pace, and
thereby drive the global market.
Competitive Landscape:
·
Eli Lilly and Company
·
Concordia International Corp
·
NEOS Therapeutics Inc
·
Highland Therapeutics Inc
·
Pfizer Inc
·
Novartis AGNoven Pharmaceuticals Inc
·
Janssen Global Services LLC
·
Shire
·
Teva Pharmaceutical
Market Segmentation:
·
The global ADHD therapeutics market has been
segmented in terms of distribution channels and drug types.
·
By drug types, the market divides into
non-stimulants and stimulants.
·
By distribution channel, the market comprises
pharmacies, research laboratories, hospitals, clinics, and others.
Regional Analysis:
The
global ADHD therapeutics market is geographically distributed across the
following key regions: Asia Pacific, North America, Europe, South America and
the Middle East & Africa.
The global ADHD
therapeutics market is spearheaded by North America as per the market study of
2015, wherein the region enjoyed a massive 68.2% of the market share. Both
Europe and Asia Pacific regional markets are expected to be the fastest growing
markets over the review period
Comments
Post a Comment